Paperback Edition
Paperback
91 pages
$25.95
Choose vendor to order paperback edition
BrownWalker Press
Amazon.com
Barnes & Noble
Harvard Book Store
Return policy
PDF eBook
Entire PDF eBook
945kB
$24
Get instant access to an entire eBook
Buy PDF Password
Download Complete PDF
eBook editions
Standardization of Quality of Life Core Outcomes in Stem Cell Clinical Trials
Paperback
eBook PDF
Publisher: | Dissertation |
Pub date: | 2018 |
Pages: | 91 |
ISBN-10: | 1612334660 |
ISBN-13: | 9781612334660 |
Categories: | Health Sciences Medicine Science |
Abstract
Background: Establishing standardized Quality of Life (QOL) core outcomes in stem cell clinical trials is important to ensure (1) researchers and clinicians can make informed decisions, and (2) clinical trials use and consistently measure the same units (Clarke, 2007; Thornley & Adams, 1998). This study reviews the most common QOL methodologies, timing/frequency of the measurement, and outcomes in cardiovascular stem cell clinical trials.Methods: To identify instruments, the study reviewed MEDLINE, Scopus, and US Clinical Trials Register through September 2010, and randomized BMSC controlled trials of clinical trials from 2000-2011. The trials all used the terms (bone marrow stem cell AND quality of life OR heart OR cardiac) AND cardiac AND quality of life OR QOL. The study included a Likert scale web-based questionnaire comprised of eight questions designed to assess QOL patient satisfaction post cardiovascular stem cell treatment.
Results: Of the instruments identified, the study found that bone marrow stem cell (BMSC) clinical trials used 35 different types of methodologies, whereas cardiovascular BMSC employed more consistent methodologies. Timing, frequency, and baseline were consistently measured in BMSC clinical trials, whereas cardiovascular BMSC lacked baseline consistency and were measured primarily after treatment. Cardiovascular BMSC outcomes were consistent, whereas BMSC clinical trials had multiple outcomes.
The mean participant age was 56.25 years with a minimum age of 46 years and a maximum age of 61 years. Participants generally were educated with a minimum education level of an Associate degree and a maximum degree of Doctorate. The patient satisfaction survey revealed that participants preferred yes/no questions and surveys that required less than 15 minutes to complete, received via email, easy to understand, not too personal, relevant to feelings, containing a baseline measure, and medical-condition specific.
Conclusion: QOL outcomes are rarely assessed in BMSC cardiovascular trials. Treatments are performed all over the world, and no one knows whether these treatments actually are effective. Both standardized measurements and additional studies are needed.
About the Author
Dori Naerbo, PhD, MSBA and MSc is a University of Liverpool graduate and specialises in stem cell clinical trials, commercialisation of cellular treatments and business development. Dr. Naerbo is a successful entrepreneur and author with over twenty years of diverse business experience. Areas of expertise include biotech, clinical research, global knowledge management (KM), R&D (special interest in cardiovascular stem cell applications), life science (Phase I and II), mentoring and crisis management. Dori provides access to her network of world class scientists and researchers in manufacturing, cellular technologies and treatments. Dori speaks English and Norwegian, and holds a Ph.D. in Organisation Psychology, MSc in Business Administration and MSc in Clinical Research.
Paperback Edition
Paperback
91 pages
$25.95
Choose vendor to order paperback edition
BrownWalker Press
Amazon.com
Barnes & Noble
Harvard Book Store
Return policy
PDF eBook
Entire PDF eBook
945kB
$24
Get instant access to an entire eBook
Buy PDF Password
Download Complete PDF
eBook editions
Share this book
Relevant events
JAN
12
8NIF2025
8TH ANNUAL NEUROSCIENCE INNOVATION FORUM
12TH JANUARY 2025 | MARINES' MEMORIAL CLUB | SAN FRANCISCO | USA
ABOUT THE #Sachs_NIF FOR...
12 - 12 Jan 2025
San Francisco, United States
MAR
13
PHARMA 2025
12th Edition of Global Conference on Pharmaceutics and Novel Drug Delivery Systems
Join us for the distinguished 12th Edition of the Global Conference on Pharmaceutics and Nove...
13 - 15 Mar 2025
Online Event | Italy
MAR
21
34th Euro Dentistry Congress
Welcome to the 34th Euro Dentistry Congress, scheduled to take place on March 21-22, 2025, in...
21 - 22 Mar 2025
Paris, France
APR
25
AACR25
AACR Annual Meeting 2025
AACR Annual Meeting 2025
AACR Annual Meeting Committees
The AACR Annual Meeting is the cr...
25 - 30 Apr 2025
Chicago, United States
JUN
15
NC2025
Neurology Conference 2025 in USA
Sessions
Neurological Implications of Post-Infectious Syndromes
Virtual Reality in Neurolog...
15 - 16 Sep 2025
Los Angeles, United States
JUN
23
SOFE2025
Symposium on Fusion Engineering 2025
Hosted by the MIT Plasma Science & Fusion Center at MIT's campus in Cambridge, MA
We at th...
23 - 26 Jun 2025
Cambridge, United States
SEP
15
CARDIO 2025
6th Edition of Cardiology World Conference
Step into the future of cardiology at the 6th Edition of Cardiology World Conference, where p...
15 - 17 Sep 2025
London, United Kingdom
JAN
13
BIOLOGIC
BioLogic Summit 2025
The conference will focus on real-world applications and examples that showcase recent breakt...
13 - 16 Jan 2025
San Diego, United States
JAN
27
37th Annual Selected Topics in Internal Medicine
Mayo Clinic's Selected Topics in Internal Medicine (STIM) is a postgraduate course designed t...
27 - 31 Jan 2025
Waimea, United States
FEB
3
SCOPE
SCOPE: Summit For Clinical Ops Executives 2025
Clinical trials and clinical research are essential for advancing medical knowledge, improvin...
03 - 06 Feb 2025
Florida, United States